Skip to content

超基因医药

US · RARE #3012 按市值排名 上市于 1970
14.54 -0.63 -4.15%
实时 - 追踪5344个代码 - 心跳于330秒前 · 2026-10-16 19:56

最新新闻

  • 评级变动
    Goldman Sachs Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/10/4
  • 公司公告
    Rare Element Resources Ltd. | 3: Initial statement of beneficial ownership of securities- Bilant Josef
    SEC · 2026/10/6
  • 评级变动
    Ord Minnett Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Sell Rating, Cuts Target Price to $9.82
    \u5e02\u573a\u8d44\u8baf · 2026/9/29
  • CSL Strikes US$1.6 Billion Licensing Deal for Rare Disease Drug | ASX:CSL
    Proactive Investors · 2026/10/5
  • Mobix Labs Merger Partner Special Project Delivery To Combine With U.S. Rare Earth Company Winner Water Services; Terms Not Disclosed
    Benzinga · 2026/10/5
  • Ord Minnett Upgrades LYNAS RARE EARTHS LTD(LYSCF.US) to Buy Rating, Raises Target Price to $9.76
    \u5e02\u573a\u8d44\u8baf · 2026/10/5
  • Bond Selloff Is Opening up Rare Opportunities for Investors. Here Is Where to Look, Says Major Bank.
    MarketWatch · 2026/10/5
  • 评级变动
    J.P. Morgan Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $13.17
    \u5e02\u573a\u8d44\u8baf · 2026/10/3
  • 公司公告
    American Rare Earths Ltd: CSM Study Strengthens Foundation for U.S. REE Supply
    ASX · 2026/9/30
  • 评级变动
    UBS Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $14.55
    \u5e02\u573a\u8d44\u8baf · 2026/10/2
  • Lynas Rare Earths Price Target Cut 10% to A$18.00/Share by Jefferies
    Dow Jones · 2026/10/5
  • 评级变动
    William Blair Maintains LYNAS RARE EARTHS LTD SPON ADR EACH REP 1 ORD SHS(LYSDY.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/10/1
  • 公司公告
    Shionogi: Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.
    JPX · 2026/10/5
  • 评级变动
    H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $25
    \u5e02\u573a\u8d44\u8baf · 2026/9/25
  • 评级变动
    Lynas Rare Earths Price Target Cut 5% T0 A$19.00/Share by Macquarie
    Dow Jones · 2026/10/2
  • 评级变动
    Lynas Rare Earths Price Target Cut 6.7% to A$21.00/Share by UBS
    Dow Jones · 2026/10/2
  • 评级变动
    J.P. Morgan Remains a Buy on Lynas Rare Earths (LYSCF)
    TipRanks · 2026/10/3
  • 公司公告
    JX Advanced Metals: Notice Regarding the Agreement on a Joint Study for Entering the Rare Earth Refining Business with Tronox Co., Ltd.
    JPX · 2026/9/29
  • 评级变动
    Macquarie Maintains AMERICAN RARE EARTHS LTD(ARRNF.US) With Buy Rating, Cuts Target Price to $0.38
    \u5e02\u573a\u8d44\u8baf · 2026/10/1
  • 公司公告
    Xiamen Tungsten Co., Ltd.: Notice Regarding the Acceptance of the Application for a Public Offering of Shares and Listing on the Beijing Stock Exchange by Its Controlling Subsidiary, Jinlong Rare Earth
    SZSI · 2026/10/1

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:56:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

超基因医药 讨论区 0 条评论

发表评论